{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:10:42Z","timestamp":1692641442567},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1006\/exnr.1998.6859","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:00:46Z","timestamp":1033930846000},"page":"238-242","source":"Crossref","is-referenced-by-count":5,"title":["Trihexyphenidyl Potentiation ofl-DOPA: Reduced Effectiveness Three Years Later in MPTP-Induced Chronic Hemiparkinsonian Monkeys"],"prefix":"10.1006","volume":"152","author":[{"given":"Edward F.","family":"Domino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.6859_EN986859RF1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life. Sci."},{"key":"10.1006\/exnr.1998.6859_EN986859RF2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870090204","article-title":"N-0923, a selective dopamine D2","volume":"9","author":"Belluzzi","year":"1994","journal-title":"Movement Dis."},{"key":"10.1006\/exnr.1998.6859_EN986859RF3","first-page":"221","article-title":"Nd121","volume":"164","author":"Domino","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.1998.6859_EN986859RF4","first-page":"1387","article-title":"Relative potency and efficacy of some dopamine agonists with varying selectivities for D12","volume":"165","author":"Domino","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.1998.6859_EN986859RF5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(97)00129-5","article-title":"Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP induced hemiparkinsonian monkeys","volume":"325","author":"Domino","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6859_EN986859RF6","doi-asserted-by":"crossref","unstructured":"Domino, E. F. L. Ni, H. Zhang, Y. Kohno, M. Sasa, 1998, Effects of talipexole on contraversive rotation and functional impairments in MPTP induced hemiparkinsonian monkeys, Jpn. J. Pharmacol. in press","DOI":"10.1254\/jjp.77.227"},{"key":"10.1006\/exnr.1998.6859_EN986859RF7","doi-asserted-by":"crossref","unstructured":"Emborg-Knott, M. E. E. F. Domino, 1998, MPTP-induced hemiparkinsonism in nonhuman primates 6\u20138 years after a single intracarotid dose, Exp. Neurol.\/Neurodegeneration, in press","DOI":"10.1006\/exnr.1998.6845"},{"key":"10.1006\/exnr.1998.6859_EN986859RF8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.1986.tb11123.x","article-title":"Binding and functional profiles of the selective M1","volume":"89","author":"Giachetti","year":"1986","journal-title":"Brit. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6859_EN986859RF9","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","article-title":"Treatment of central nervous system degenerative disorders","author":"Standaert","year":"1996"},{"key":"10.1006\/exnr.1998.6859_EN986859RF10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0006-2952(85)90196-0","article-title":"Trihexyphenidyl-Further evidence for muscarinic receptor subclassification","volume":"34","author":"Tien","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/exnr.1998.6859_EN986859RF11","series-title":"Neurodegenerative Diseases","first-page":"573","article-title":"Chapter 34. Treatment of Parkinson's Disease","author":"Tsui","year":"1994"},{"key":"10.1006\/exnr.1998.6859_EN986859RF12","series-title":"The Neurosciences Third Study Program","first-page":"695","article-title":"Chapter 60. Brain dopamine neurons and behavior","author":"Ungerstedt","year":"1974"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698968595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698968595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:35:57Z","timestamp":1576578957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488698968595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S0014488698968595"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.6859","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}